Wound Management Technologies, Fort Worth, Texas, has acquired BioPharma Management Technologies, a privately held biotech company also in Fort Worth. BioPharma specializes in development of proprietary and patented topical pain-management technologies.
Wound Management Technologies acquires biotech firm
The all-stock deal called for Wound Management to distribute 4.5 million shares of stock to BioPharma shareholders. Based on Wound Management’s most recent over-the-counter trading price of $2.75 per share, which took place on Sept.11, the transaction is valued at roughly $12 million.
What do you think? Post a comment on this article and share your opinion with other readers. Submit your comments to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.